The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study indicates that disclosing APOE genotypes and communicating the associated risk of AD to asymptomatic individuals [26], as well as the progression of MCI to mild AD dementia does not generally cause psychological harm [28]. The gene discussed is APOE; the disease is Alzheimer disease.